Global Aptamer Market Expected to Grow at a CAGR of 20.0% till 2025

ALBANY, USA, 2018-Apr-06 — /EPR Network/ —Aptamers are chemically synthesized single-standard oligonucleotides. Aptamers offer relative cost advantage and are developed through more reliable process than monoclonal antibodies. The global aptamer market was valued approximately US$ 1.0 Bn in 2016 and is anticipated to register CAGR of over 20.0% from 2017 to 2025 to reach value of approximately US$ 5.0 Bn by 2025.  Advancement in technologies for selection of aptamer and increasing interest of research scientists in the field of aptamer technology owing to various advantages over antibodies are likely to fuel expansion of the global cardiovascular drugs market from 2017 to 2025.

Click to get Sample PDF: https://www.mrrse.com/sample/4655

Aptamers are single-standard oligonucleotides that bind to the target molecules such as proteins with high specificity. These offer great potential to develop novel applications in the field of diagnostic, research and therapeutic. Aptamers illustrate lock-and-key relationship between aptamer molecules and binding partners i.e., target molecules. The procedure commonly used for the selection of aptamers for a specific target molecule is known as SELEX process. Several modifications in the SELEX procedure have been introduced in order to improve aptamer selectivity or to reduce the time for selection. Blended SELEX, counter SELEX, subtractive SELEX, automated SELEX and atomic force microscopy-SELEX are some of the commercially available modified SELEX procedures. Key players are investing in to develop new drugs base aptamer with better efficacy. Ophthotech Corporation is projected to launch of Fovista aptamer  for treating age related macular degeneration in 2018 is likely to fuel expansion of application of aptamer in therapeutics use market segment by 2025 augmenting global aptamer market. However, lack of knowledge and unfavorable characteristics of aptamers will lead low acceptance of aptamer which is likely to hamper global aptamer market.

The global aptamer market has been segmented on the basis of material type, selection technique and geography. Among material type, nucleic acid aptamer segment is projected to lead the market and is expected to continue its dominance during the forecast period followed by peptide aptamer segment. Introduction of new nucleic acid aptamer base drug such as Macugen and developing of DNA/RNA base aptamer drug like REG1, NOX-A12 is likely to propel expansion of the segment. Among selection technique, SELEX technique was the leading revenue generating segment in 2016 and it is likely to continue its dominance during the forecast period. Others which include (MARAS technique, X-Aptamer technique) segment of indication is likely to lose its market share during the forecast period owing to the preference for SELEX technique for aptamer selection. Among various application, research and diagnostics was the leading application in 2016 and is likely to account for leading share during the forecast period.

View Complete TOC with Tables and Figures at: https://www.mrrse.com/aptamers-market

Global Aptamer Market: Regional Outlook

Geographically, the global aptamer market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, France, Italy, Spain and Rest of Europe), Asia Pacific (China, Japan, India, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico and Rest of Latin America) and Rest of World. The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the aptamer market are include AM Biotech, Aptagen, LLC., Aptamer Group, Aptamer Sciences, Inc., Base Pair Biotechnologies, CD Genomics, NeoVentures Biotechnology Inc., NAXXON Pharma, Aptus Biotech, TriLink BioTechnologies, LLC., and Pfizer Inc. among others.

Enquire about this Report @ https://www.mrrse.com/enquiry/4655

About MRRSE

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States
Telephone: +1-518-730-0559
Email: sales@mrrse.com
Website: https://www.mrrse.com/